Sublingual Targeting of STING With 3′3′-cGAMP Promotes Systemic and Mucosal Immunity Against Anthrax Toxins

Vaccine - Netherlands
doi 10.1016/j.vaccine.2017.02.064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeted Silencing of Anthrax Toxin Receptors Protects Against Anthrax Toxins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Bifunctional Immunity Proteins Protect Bacteria Against FtsZ-Targeting ADP-Ribosylating Toxins

Cell
BiochemistryGeneticsMolecular Biology
2018English

Development of Mucosal Immunity in Children: A Rationale for Sublingual Immunotherapy?

Journal of Allergy
AllergyImmunology
2012English

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma Cruzi

Frontiers in Immunology
AllergyImmunology
2020English

Comparison of Systemic and Mucosal Immunization With Helper-Dependent Adenoviruses for Vaccination Against Mucosal Challenge With SHIV

PLoS ONE
Multidisciplinary
2013English

Vaccine Candidate Blocks Pseudomonas Aeruginosa by Targeting Mucosal Immunity

Microbe
Microbiology
2012English

Serum IgG Mediates Mucosal Immunity Against Rotavirus Infection

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Decreased Levels of Autoantibody Against Histone Deacetylase 3 in Patients With Systemic Sclerosis

Autoimmunity
AllergyImmunology
2009English

Taking the Sting Out of the Anthrax Vaccine

Journal of Clinical Investigation
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy